Neogen (NEOG) Set to Release Quarterly Earnings on Tuesday

Key Points

• Neogen is scheduled to report Q1 2027 earnings before the market opens on Tuesday, October 6, 2026. Analysts expect earnings of approximately $0.053 per share and revenue of $207.9 million.
• In its previous quarter, Neogen earned $0.09 per share, exceeding the $0.06 consensus estimate, while revenue of $225.3 million also topped expectations. Year-over-year revenue declined slightly, and the company reported a negative net margin.
• NEOG shares opened at $13.72 and remain near their 52-week high of $14.26. Analyst sentiment is mixed, with a consensus “Hold” rating and an average price target of $12.00, though Piper Sandler recently upgraded the stock to “Overweight.”

Neogen (NASDAQ:NEOG - Get Free Report) is expected to post its Q1 2027 results before the market opens on Tuesday, October 6th. Analysts expect the company to announce earnings of $0.0533 per share and revenue of $207.90 million for the quarter. Interested persons can find conference call details on the company's upcoming Q1 2027 earning summary page for the latest details on the call scheduled for Tuesday, October 6, 2026 at 4:30 PM ET.

Neogen (NASDAQ:NEOG - Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.03. The business had revenue of $225.30 million during the quarter, compared to the consensus estimate of $212.35 million. Neogen had a negative net margin of 0.91% and a positive return on equity of 2.78%. The firm's revenue was down .1% on a year-over-year basis. During the same period in the previous year, the company posted ($2.82) earnings per share. On average, analysts expect Neogen to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Neogen Stock Performance

NEOG stock opened at $13.72 on Tuesday. Neogen has a one year low of $5.37 and a one year high of $14.26. The firm has a market cap of $2.99 billion, a price-to-earnings ratio of -457.33, a PEG ratio of 5.16 and a beta of 1.76. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.91 and a current ratio of 3.82. The firm has a 50-day simple moving average of $11.73 and a two-hundred day simple moving average of $10.11.

Analyst Upgrades and Downgrades

Several research analysts recently commented on NEOG shares. Piper Sandler upgraded shares of Neogen from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $13.00 to $14.00 in a research note on Wednesday, August 26th. Weiss Ratings upgraded shares of Neogen from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, August 7th. Finally, Wall Street Zen lowered shares of Neogen from a "strong-buy" rating to a "buy" rating in a report on Sunday, September 20th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $12.00.

Neogen Company Profile

Neogen Corporation develops and markets products and services designed to protect food, animals and people. The company's offerings help customers detect, prevent and manage biological, chemical and physical hazards across the food production, agricultural and animal care industries.

Its food safety portfolio includes test kits and related technologies for detecting pathogens, allergens, mycotoxins, spoilage organisms, veterinary drug residues and other contaminants. Neogen also provides sanitation and hygiene products, diagnostic tools, laboratory services, software and training for food manufacturers, processors, retailers and other organizations involved in the food supply chain.

Neogen's animal safety business serves livestock, poultry, companion animal and veterinary markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.